Pacira BioSciences, Inc. — Director's Dealing 2012

Jun 11, 2012

SEC Form 4/A — Form 4/A

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2012-06-05

Reporting Person: PATOU GARY (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-05	Stock Option (Right to Buy)	$10.81	A	40000	Acquired	2022-06-05	Common Stock (40000)	Direct

Footnotes

F1: 25% of the shares vest on June 5, 2013 and the remainder of the shares vest monthly over the following 36 months.